146 related articles for article (PubMed ID: 34152880)
1. Efficacy of topical
Mohajerani R; Shahi F; Jafariazar Z; Afshar M
Cutan Ocul Toxicol; 2021 Sep; 40(3):257-262. PubMed ID: 34152880
[TBL] [Abstract][Full Text] [Related]
2. Topical henna and curcumin (Alpha®) ointment efficacy for prevention of capecitabine induced hand-foot syndrome: A randomized, triple-blinded, placebo-controlled clinical.
Elyasi S; Rasta S; Taghizadeh-Kermani A; Hosseini S
Daru; 2022 Jun; 30(1):117-125. PubMed ID: 35320555
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a topical formulation of henna (Lawsonia inermis L.) in contact dermatitis in patients using prosthesis: A double-blind randomized placebo-controlled clinical trial.
Niazi M; Mehrabani M; Namazi MR; Salmanpour M; Heydari M; Karami MM; Parvizi MM; Fatemi I; Mehrbani M
Complement Ther Med; 2020 Mar; 49():102316. PubMed ID: 32147071
[TBL] [Abstract][Full Text] [Related]
4. Topical henna for capecitabine induced hand-foot syndrome.
Yucel I; Guzin G
Invest New Drugs; 2008 Apr; 26(2):189-92. PubMed ID: 17885735
[TBL] [Abstract][Full Text] [Related]
5. The effect of a topical formulation from Lawsonia inermis L. (henna) on pain intensity in patients with chronic sciatica: A randomized double-blind clinical trial.
Lavari N; Ostadrahimi N; Rahimi R; Raei M; Abbassian A
J Ethnopharmacol; 2023 Sep; 313():116519. PubMed ID: 37105368
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of skin cancer: effect of Lawsonia inermis L. (Henna) leaf powder and its pigment artifact, lawsone in the Epstein- Barr virus early antigen activation assay and in two-stage mouse skin carcinogenesis models.
Kapadia GJ; Rao GS; Sridhar R; Ichiishi E; Takasaki M; Suzuki N; Konoshima T; Iida A; Tokuda H
Anticancer Agents Med Chem; 2013 Dec; 13(10):1500-7. PubMed ID: 23848207
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical and clinical studies of celecoxib topical hydrogel for management of chemotherapy-induced hand-foot syndrome.
Shayeganmehr D; Ramezannia F; Gharib B; Rezaeilaal A; Shahi F; Jafariazar Z; Afshar M
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1571-1581. PubMed ID: 36418469
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of henna (Lawsonia inermis L.) mouthwash versus chlorhexidine gluconate 0.2% mouthwash as adjuvant therapy of oral lichen planus: A randomized double-blind clinical trial.
Kakoei S; Karbasi N; Raeiszadeh M; Tajadini H; Nekouei AH
J Ethnopharmacol; 2022 May; 290():115037. PubMed ID: 35134489
[TBL] [Abstract][Full Text] [Related]
9. Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.
Santhosh A; Sharma A; Bakhshi S; Kumar A; Sharma V; Malik PS; Pramanik R; Gogia A; Prasad CP; Sehgal T; Gund S; Dev A; Cheung WY; Pandey RM; Kumar S; Gupta I; Batra A;
J Clin Oncol; 2024 May; 42(15):1821-1829. PubMed ID: 38412399
[TBL] [Abstract][Full Text] [Related]
10. Lawsonia inermis L. (henna): ethnobotanical, phytochemical and pharmacological aspects.
Badoni Semwal R; Semwal DK; Combrinck S; Cartwright-Jones C; Viljoen A
J Ethnopharmacol; 2014 Aug; 155(1):80-103. PubMed ID: 24886774
[TBL] [Abstract][Full Text] [Related]
11. Topical henna ameliorated capecitabine-induced hand-foot syndrome.
Ilyas S; Wasif K; Saif MW
Cutan Ocul Toxicol; 2014 Sep; 33(3):253-5. PubMed ID: 24021017
[TBL] [Abstract][Full Text] [Related]
12. Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
Elyasi S; Shojaee FSR; Allahyari A; Karimi G
Phytother Res; 2017 Sep; 31(9):1323-1329. PubMed ID: 28635153
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled feasibility trial to evaluate Lawsonia inermis (henna)'s effect on palmar-plantar erythrodysesthesia induced by capecitabine or pegylated liposomal doxorubicin.
Stavrinou M; Tsitsi T; Astras G; Paikousis L; Charalambous A
Eur J Oncol Nurs; 2021 Apr; 51():101908. PubMed ID: 33626423
[TBL] [Abstract][Full Text] [Related]
14. Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study).
Santhosh A; Kumar A; Pramanik R; Gogia A; Prasad CP; Gupta I; Gupta N; Cheung WY; Pandey RM; Sharma A; Batra A
Trials; 2022 May; 23(1):420. PubMed ID: 35590388
[TBL] [Abstract][Full Text] [Related]
15. Preliminary investigation of the effects of topical mixture of Lawsonia inermis L. and Ricinus communis L. leaves extract in treatment of osteoarthritis using MIA model in rats.
Ziaei A; Sahranavard S; Gharagozlou MJ; Faizi M
Daru; 2016 May; 24(1):12. PubMed ID: 27142000
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effect of
Zheng Y; Hu Y; Liu K; Lu Y; Hu Y; Zhou X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1376-1380. PubMed ID: 31852654
[TBL] [Abstract][Full Text] [Related]
17. Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study.
Meadows KL; Rushing C; Honeycutt W; Latta K; Howard L; Arrowood CA; Niedzwiecki D; Hurwitz HI
Support Care Cancer; 2015 May; 23(5):1311-9. PubMed ID: 25341548
[TBL] [Abstract][Full Text] [Related]
18. Topical administration of hydroethanolic extract of Lawsonia inermis (henna) accelerates excisional wound healing process by reducing tissue inflammation and amplifying glucose uptake.
Daemi A; Farahpour MR; Oryan A; Karimzadeh S; Tajer E
Kaohsiung J Med Sci; 2019 Jan; 35(1):24-32. PubMed ID: 30844141
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of the Algerian Lawsonia inermis (henna).
Rahmoun N; Boucherit-Otmani Z; Boucherit K; Benabdallah M; Choukchou-Braham N
Pharm Biol; 2013 Jan; 51(1):131-5. PubMed ID: 23126251
[TBL] [Abstract][Full Text] [Related]
20. Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.
Wolf SL; Qin R; Menon SP; Rowland KM; Thomas S; Delaune R; Christian D; Pajon ER; Satele DV; Berenberg JL; Loprinzi CL;
J Clin Oncol; 2010 Dec; 28(35):5182-7. PubMed ID: 21060036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
